BAW2881 (NVP-BAW2881)

BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor tyrosine-kinase inhibitor that potently inhibits VEGFR1-3 at 1.0-4.3 nanomolar (nM) concentrations and inhibits PDGFRβ, c-Kit, and RET (c-RET) at 45-72 nM concentrations.

Price Not Available 5mg BAW2881 (NVP-BAW2881) Supplier Page

Trivial name	N/A
Catalog Number	S8189
Molecular Formula	C22H15F3N4O2
CAS#	861875-60-7
Inchi	InChI=1S/C22H15F3N4O2/c23-22(24,25)14-4-2-5-15(12-14)28-20(30)18-6-1-3-13-11-16(7-8-17(13)18)31-19-9-10-27-21(26)29-19/h1-12H,(H,28,30)(H2,26,27,29)
Inchi Key	MLLQJNIKDWEEFT-UHFFFAOYSA-N
SMILES	C1=CC(=CC(=C1)NC(=O)C2=CC=CC3=C2C=CC(=C3)OC4=NC(=NC=C4)N)C(F)(F)F
Size	5mg
Supplier Page	http://www.selleckchem.com/products/baw2881-nvp-baw2881.html
Additional Information	https://file.selleck.cn/downloads/struct/baw2881-nvp-baw2881-chemical-structure-s8189.gif